Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
291.30
-5.05 (-1.7%)
BSENSE

Nov 20

BSE+NSE Vol: 1.95 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Fredun Pharma
Shukra Pharma.
Sakar Healthcare
Unichem Labs.
Solara Active
Gufic BioScience
RPG LifeScience.
Ind-Swift Labs.
Hikal
Indoco Remedies
Advanced Enzyme
Why is Advanced Enzyme Technologies Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -0.47% of over the last 5 years
2
Stock is technically in a Mildly Bearish range
  • The stocks MACD and KST technical factors are also Bearish
3
With ROE of 9.8, it has a Very Expensive valuation with a 1.9 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -10.24%, its profits have risen by 10.2% ; the PEG ratio of the company is 1.6
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -10.24% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Advanced Enzyme for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Advanced Enzyme
-10.24%
-0.26
39.45%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
7.87%
EBIT Growth (5y)
-0.47%
EBIT to Interest (avg)
57.21
Debt to EBITDA (avg)
0.20
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
0.45
Tax Ratio
25.87%
Dividend Payout Ratio
44.37%
Pledged Shares
0
Institutional Holding
28.54%
ROCE (avg)
18.65%
ROE (avg)
9.85%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
20
Industry P/E
37
Price to Book Value
1.91
EV to EBIT
13.00
EV to EBITDA
10.74
EV to Capital Employed
2.44
EV to Sales
3.27
PEG Ratio
1.56
Dividend Yield
0.48%
ROCE (Latest)
18.78%
ROE (Latest)
9.76%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
NET SALES(Q)

Highest at Rs 214.51 cr

PBDIT(Q)

Highest at Rs 72.12 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 33.62%

PBT LESS OI(Q)

Highest at Rs 60.04 cr.

PAT(Q)

Highest at Rs 48.31 cr.

EPS(Q)

Highest at Rs 4.38

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Advanced Enzyme
Net Sales - Quarterly
Highest at Rs 214.51 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 72.12 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 33.62%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 60.04 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 60.04 cr has Grown at 21.88%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 48.31 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 4.38
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)